Qing Zhou

Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute

China

SCHOLARLY PAPERS

4

DOWNLOADS

77

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

The Resistance Landscape of Abivertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, and Clinical Strategy to Overcome Resistance in EGFR T790M-Positive Non-Small Cell Lung Cancer

Number of pages: 37 Posted: 28 Jan 2019
Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences, ACEA Therapeutics Inc., ACEA Therapeutics Inc., ACEA Therapeutics Inc., Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute and Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute
Downloads 35 (556,409)

Abstract:

Loading...

Abivertinib, resistance, EGFR amplification

2.

Bevacizumab Plus Erlotinib in Chinese Patients with Untreated, EGFR-Mutated, Advanced NSCLC (ARTEMIS-CTONG1509): A Multicenter Phase 3 Study

Number of pages: 56 Posted: 19 Dec 2020
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Jilin Provincial Tumor Hospital - Department of Thoracic Oncology, China Medical University - Department of Medical Oncology, Harbin Medical University - Cancer Hospital, Jilin University (JLU) - The Cancer Center, Central South University - Department of Medical Oncology, Nanjing Military General Hospital - Respiratory Medicine, China Medical University - Medical Oncology Department of Thoracic Cancer, Shanghai Jiao Tong University (SJTU) - Medical Oncology, Zhejiang University - Respiratory Medicine, Henan Cancer Hospital - Respiratory Medicine, Huazhong University of Science and Technology (Formerly Tongi Medical University) - Medical Oncology, Fujian Cancer Hospital - Medical Oncology, Nanjing Medical University - Department of Oncology and Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute
Downloads 22 (636,488)
Citation 1

Abstract:

Loading...

bevacizumab, EGFR mutation, epidermal growth factor inhibitor, erlotinib, non-small-cell lung cancer, vascular endothelial growth factor inhibitor

3.

Genomic Signature for Personalized Adjuvant Therapy in Resected EGFR-Mutant Stage II-III Non-Small Cell Lung Cancer: Results from Phase 3 ADJVANT/CTONG1104 Study

Number of pages: 30 Posted: 28 Oct 2020
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Fudan University - Zhongshan Hospital, Zhejiang Cancer Hospital, Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Central South University - Hunan Cancer Hospital, Fujian Medical University - Union Hospital, Jilin Provincial Cancer Hospital, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Geneseeq Technology Inc. - Geneseeq Research Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute and Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute
Downloads 13 (702,640)

Abstract:

Loading...

Adjuvant therapy, EGFR, TKI, chemotherapy, non-small cell lung cancer

4.

Genomic Stability and Non-Exhausted Immune Phenotype in Indolent T4N0M0 (Diameter ≥7 cm) Non-Small Cell Lung Cancers

Number of pages: 33 Posted: 15 Sep 2021
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Southern Medical University - Second School of Clinical Medicine, Geneplus-Beijing Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Geneplus-Beijing Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Geneplus-Beijing Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Geneplus-Beijing Institute, Geneplus-Beijing Co. Ltd., Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute and Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute
Downloads 7 (750,043)

Abstract:

Loading...

intra-tumoural heterogeneity, clonal structure, chromosomal instability, indolent tumour, non-small cell lung cancer